Effectiveness of physiotherapy combined with standard Ayurveda treatments (a personalized treatment regime with a combination of Kashaya, Arishta, pills and oils) versus physiotherapy with placebo in improving functional activities in ischemic stroke patients: A Randomized Controlled Trial

A single-center, randomized, six month, parallel-group, study to compare the effectiveness of a combination of physiotherapy and Ayurveda treatment versus physiotherapy and placebo in ischemic stroke rehabilitation.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

SLCTR

Registry ID

SLCTR/2021/021

Enrollment

Unknown

Registered

2021-07-26

Start date

2021-07-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

-The study will be a randomized, participant blinded, placebo-controlled clinical trial. It will be conducted at the Ward 61 & 62, Professorial Unit, Teaching Hospital, Anuradhapura, Sri Lanka. -Elig

Eligibility

Inclusion criteria

Inclusion criteria: • Patients confirmed to have an ischemic stroke • Patients above 18 years of age * Both men and women • Barthel Index 0-50 (severely disabled patients) • NIHSS score (The National Institutes of Health Stroke Scale Score) 5-20 on admission. • Non- thrombolysis patients

Exclusion criteria

Exclusion criteria: • Stroke mimics (A nonvascular disease that presents with stroke-like symptoms, often indistinguishable from an actual stroke) Eg: brain tumors (gliomas, meningiomas, adenomas) * Toxic/ metabolic disorders ( hypoglycemia, hypercalcemia, hyponatremia, uremia, hepatic encephalopathy, hyperthyroidism, thyroid storm) * Infectious disorders (meningio encephalitis) * Psychological disorders * Migraines * Seizures * Demyelination disorders • Posterior circulation stroke • Hemorrhagic strokes • Patients without a caregiver, relative or a supporting family

Design outcomes

Primary

Measure	Time frame
% change in global disability using Barthel Index [At the baseline, at the end of three months and six months of starting the treatments]	—

Secondary

Measure	Time frame
% change in motor functions using the Motor Assessment Scale (MAS) [At the baseline, at the end of three months and six months of starting the treatments] % change in risk of falls using the Berg Balance Scale (BBS) [ At the baseline, at the end of three months and six months of starting the treatments] % change in ability to walk independently using New Functional Ambulation Category (FAC) [ At the baseline, at the end of three months and six months of starting the treatments] [] []	—

Measure

Time frame

% change in motor functions using the Motor Assessment Scale (MAS) [At the baseline, at the end of three months and six months of starting the treatments] % change in risk of falls using the Berg Balance Scale (BBS) [ At the baseline, at the end of three months and six months of starting the treatments] % change in ability to walk independently using New Functional Ambulation Category (FAC) [ At the baseline, at the end of three months and six months of starting the treatments] [] []

—

Countries

Sri Lanka

Contacts

Public ContactY.M.N.M.Wickramasinghe

Temporary Lecturer

nadeeshawick1987@gmail.com0252227706

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026